发明名称 CD45RB BONDING COMPOUND FOR PREVENTING GRAFT REJECTION
摘要 <p><P>PROBLEM TO BE SOLVED: To provide a new compound and a new medicinal composition each useful for controlling immune response. <P>SOLUTION: The method is for treating or preventing graft rejection for cell, organization or organ of a receptor, wherein the method comprises administering a pharmacologically effective amount of at least one compound bondable to CD45RB leukocyte antigen for inhibiting T-cell internuncial immune response of the receptor against the graft. <P>COPYRIGHT: (C)2004,JPO</p>
申请公布号 JP2004067700(A) 申请公布日期 2004.03.04
申请号 JP20030332390 申请日期 2003.09.24
申请人 RESEARCH CORP TECHNOLOGIES INC 发明人 LAZAROVITS ANDREW I;POPPEMA SIBRANDES
分类号 C12N15/02;A61K31/164;A61K31/421;A61K31/436;A61K31/573;A61K38/00;A61K38/45;A61K39/395;A61K45/00;A61K47/00;A61P19/02;A61P25/00;A61P29/00;A61P37/06;C07K16/28;C07K16/40;C12P21/08;C12R1/91;(IPC1-7):A61K45/00 主分类号 C12N15/02
代理机构 代理人
主权项
地址